Suppliers / Basf

Basf

United States 8 duplicate records merged Updated 9 July 2026

Basf is an API manufacturer based in United States. It holds 9 active US drug master files across a filed portfolio of 6 molecules. Its filings concentrate with EEC_EAEU, URPL (PL) and MINSA (CR). Its GMP standing is certified by ANSM (FR), US FDA and MFDS (Korea), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 29 May 2025 as VAI.

9
active US DMFs
0
valid CEPs
5
registered plants 3 with an FDA FEI number
57
filings across 10 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 29 May 2025 VAI US FDA
  • 11 September 2024 NAI US FDA
  • 22 July 2024 VAI US FDA
  • 9 October 2018 NAI US FDA
  • 17 November 2017 VAI US FDA
  • 23 October 2015 VAI US FDA
  • 20 February 2014 NAI US FDA
  • 25 October 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SAINT VULBAS, France Not on file
Prior Velho, Portugal Not on file
Bishop, United States 3001451837
Geismar, United States 2316568
East Setauket, United States 1000521506

What they file, and where

Molecule Regulators Docs
Ibuprofen SFDA (Saudi Arabia), US FDA 4
Omega-3 Fatty Acids US FDA 2
Icosapent Ethyl US FDA 1
Omega-3-Acid Ethyl Esters US FDA 1
Poloxalene US FDA 1
Polyethylene Glycol US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
EEC_EAEU 26 None
URPL (PL) 9 None
MINSA (CR) 6 None
US FDA 6 3
EMA 4 None
INFARMED (PT) 2 2
ANSM (FR) None 8
MFDS (Korea) None 2

Comparing suppliers?

Choose your molecules and target markets. Basf comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 29 May 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates